Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001933414-24-000016
Filing Date
2024-05-09
Accepted
2024-05-09 07:10:05
Documents
55
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mlys-20240331.htm   iXBRL 10-Q 616190
2 EX-31.1 mlys-1q2410qex311.htm EX-31.1 9811
3 EX-31.2 mlys-1q2410qex312.htm EX-31.2 9748
4 EX-32.1 mlys-1q2410qex321.htm EX-32.1 5048
5 EX-32.2 mlys-1q2410qex322.htm EX-32.2 4952
  Complete submission text file 0001933414-24-000016.txt   3603940

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mlys-20240331.xsd EX-101.SCH 28661
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mlys-20240331_cal.xml EX-101.CAL 34398
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mlys-20240331_def.xml EX-101.DEF 115469
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mlys-20240331_lab.xml EX-101.LAB 379950
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mlys-20240331_pre.xml EX-101.PRE 264557
59 EXTRACTED XBRL INSTANCE DOCUMENT mlys-20240331_htm.xml XML 324798
Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Filer) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41614 | Film No.: 24928527
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)